NATCO PHARMA
|
NATCO PHARMA Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹37 Cr | ₹37 Cr | ₹37 Cr | ₹36 Cr | ₹37 Cr |
Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
Equity - Issued | ₹37 Cr | ₹37 Cr | ₹37 Cr | ₹36 Cr | ₹37 Cr |
Equity Paid Up | ₹37 Cr | ₹37 Cr | ₹37 Cr | ₹36 Cr | ₹37 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | - | ₹3.40 Cr | ₹18 Cr | ₹24 Cr | ₹31 Cr |
Total Reserves | ₹4,837 Cr | ₹4,224 Cr | ₹4,068 Cr | ₹3,714 Cr | ₹3,422 Cr |
Securities Premium | ₹1,407 Cr | ₹1,408 Cr | ₹1,392 Cr | ₹1,373 Cr | ₹1,405 Cr |
Capital Reserves | ₹52 Cr | ₹52 Cr | ₹52 Cr | ₹52 Cr | ₹21 Cr |
Profit & Loss Account Balance | ₹3,292 Cr | ₹2,667 Cr | ₹2,568 Cr | ₹2,239 Cr | ₹1,937 Cr |
General Reserves | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr |
Other Reserves | ₹27 Cr | ₹38 Cr | ₹-3.20 Cr | ₹-9.50 Cr | ₹-0.40 Cr |
Reserve excluding Revaluation Reserve | ₹4,837 Cr | ₹4,224 Cr | ₹4,068 Cr | ₹3,714 Cr | ₹3,422 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹4,874 Cr | ₹4,264 Cr | ₹4,122 Cr | ₹3,774 Cr | ₹3,489 Cr |
Minority Interest | - | - | ₹1.80 Cr | ₹11 Cr | ₹2.00 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | ₹0.90 Cr | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | ₹0.90 Cr | - |
Deferred Tax Assets / Liabilities | ₹12 Cr | ₹30 Cr | ₹41 Cr | ₹26 Cr | ₹12 Cr |
Deferred Tax Assets | ₹195 Cr | ₹128 Cr | ₹65 Cr | ₹45 Cr | ₹29 Cr |
Deferred Tax Liability | ₹208 Cr | ₹158 Cr | ₹106 Cr | ₹71 Cr | ₹40 Cr |
Other Long Term Liabilities | ₹2.80 Cr | ₹9.30 Cr | ₹2.00 Cr | ₹0.80 Cr | ₹0.80 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹85 Cr | ₹96 Cr | ₹100 Cr | ₹90 Cr | ₹71 Cr |
Total Non-Current Liabilities | ₹101 Cr | ₹135 Cr | ₹143 Cr | ₹118 Cr | ₹83 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹264 Cr | ₹162 Cr | ₹146 Cr | ₹255 Cr | ₹217 Cr |
Sundry Creditors | ₹264 Cr | ₹162 Cr | ₹146 Cr | ₹255 Cr | ₹217 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹227 Cr | ₹127 Cr | ₹100 Cr | ₹96 Cr | ₹110 Cr |
Bank Overdraft / Short term credit | ₹9.40 Cr | ₹17 Cr | ₹16 Cr | ₹14 Cr | - |
Advances received from customers | ₹86 Cr | ₹3.00 Cr | ₹1.30 Cr | ₹0.40 Cr | ₹19 Cr |
Interest Accrued But Not Due | - | - | - | - | ₹0.60 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹132 Cr | ₹107 Cr | ₹82 Cr | ₹82 Cr | ₹90 Cr |
Short Term Borrowings | ₹165 Cr | ₹404 Cr | ₹266 Cr | ₹315 Cr | ₹386 Cr |
Secured ST Loans repayable on Demands | ₹75 Cr | ₹289 Cr | ₹128 Cr | ₹134 Cr | ₹104 Cr |
Working Capital Loans- Sec | ₹75 Cr | ₹289 Cr | ₹128 Cr | ₹134 Cr | ₹104 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹15 Cr | ₹-174 Cr | ₹9.00 Cr | ₹47 Cr | ₹179 Cr |
Short Term Provisions | ₹27 Cr | ₹18 Cr | ₹14 Cr | ₹19 Cr | ₹16 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹10 Cr | ₹0.90 Cr | ₹1.30 Cr | ₹8.50 Cr | ₹6.60 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹17 Cr | ₹17 Cr | ₹13 Cr | ₹11 Cr | ₹9.00 Cr |
Total Current Liabilities | ₹683 Cr | ₹710 Cr | ₹526 Cr | ₹685 Cr | ₹729 Cr |
Total Liabilities | ₹5,657 Cr | ₹5,109 Cr | ₹4,792 Cr | ₹4,588 Cr | ₹4,303 Cr |
ASSETS | |||||
Gross Block | ₹3,375 Cr | ₹3,127 Cr | ₹2,702 Cr | ₹2,149 Cr | ₹1,695 Cr |
Less: Accumulated Depreciation | ₹948 Cr | ₹815 Cr | ₹679 Cr | ₹564 Cr | ₹467 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹2,427 Cr | ₹2,312 Cr | ₹2,023 Cr | ₹1,584 Cr | ₹1,227 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹64 Cr | ₹130 Cr | ₹223 Cr | ₹518 Cr | ₹638 Cr |
Non Current Investments | ₹87 Cr | ₹104 Cr | ₹152 Cr | ₹84 Cr | ₹20 Cr |
Long Term Investment | ₹87 Cr | ₹104 Cr | ₹152 Cr | ₹84 Cr | ₹20 Cr |
Quoted | - | ₹40 Cr | ₹70 Cr | ₹50 Cr | - |
Unquoted | ₹87 Cr | ₹64 Cr | ₹82 Cr | ₹34 Cr | ₹20 Cr |
Long Term Loans & Advances | ₹78 Cr | ₹72 Cr | ₹44 Cr | ₹72 Cr | ₹63 Cr |
Other Non Current Assets | ₹0.30 Cr | ₹4.70 Cr | ₹4.30 Cr | ₹4.20 Cr | ₹8.40 Cr |
Total Non-Current Assets | ₹2,657 Cr | ₹2,622 Cr | ₹2,447 Cr | ₹2,262 Cr | ₹1,956 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹305 Cr | ₹204 Cr | ₹152 Cr | ₹29 Cr | ₹149 Cr |
Quoted | ₹101 Cr | ₹82 Cr | ₹23 Cr | ₹5.00 Cr | ₹6.80 Cr |
Unquoted | ₹204 Cr | ₹122 Cr | ₹129 Cr | ₹24 Cr | ₹142 Cr |
Inventories | ₹743 Cr | ₹762 Cr | ₹798 Cr | ₹558 Cr | ₹529 Cr |
Raw Materials | ₹216 Cr | ₹244 Cr | ₹337 Cr | ₹160 Cr | ₹211 Cr |
Work-in Progress | ₹129 Cr | ₹175 Cr | ₹183 Cr | ₹157 Cr | ₹141 Cr |
Finished Goods | ₹279 Cr | ₹206 Cr | ₹130 Cr | ₹114 Cr | ₹74 Cr |
Packing Materials | ₹30 Cr | ₹31 Cr | ₹31 Cr | ₹26 Cr | ₹26 Cr |
Stores Ā and Spare | ₹74 Cr | ₹97 Cr | ₹77 Cr | ₹64 Cr | ₹52 Cr |
Other Inventory | ₹15 Cr | ₹9.40 Cr | ₹40 Cr | ₹37 Cr | ₹27 Cr |
Sundry Debtors | ₹856 Cr | ₹621 Cr | ₹413 Cr | ₹551 Cr | ₹506 Cr |
Debtors more than Six months | ₹20 Cr | ₹87 Cr | ₹33 Cr | - | - |
Debtors Others | ₹852 Cr | ₹576 Cr | ₹395 Cr | ₹569 Cr | ₹506 Cr |
Cash and Bank | ₹546 Cr | ₹206 Cr | ₹284 Cr | ₹66 Cr | ₹280 Cr |
Cash in hand | ₹0.30 Cr | ₹0.40 Cr | ₹0.50 Cr | ₹1.10 Cr | ₹1.80 Cr |
Balances at Bank | ₹546 Cr | ₹206 Cr | ₹283 Cr | ₹65 Cr | ₹278 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹64 Cr | ₹88 Cr | ₹95 Cr | ₹92 Cr | ₹107 Cr |
Interest accrued on Investments | ₹29 Cr | ₹25 Cr | ₹36 Cr | ₹47 Cr | ₹55 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹28 Cr | ₹33 Cr | ₹23 Cr | ₹18 Cr | ₹14 Cr |
Other current_assets | ₹7.60 Cr | ₹30 Cr | ₹36 Cr | ₹27 Cr | ₹38 Cr |
Short Term Loans and Advances | ₹486 Cr | ₹606 Cr | ₹604 Cr | ₹1,030 Cr | ₹776 Cr |
Advances recoverable in cash or in kind | ₹66 Cr | ₹100 Cr | ₹112 Cr | ₹141 Cr | ₹63 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹420 Cr | ₹506 Cr | ₹491 Cr | ₹889 Cr | ₹714 Cr |
Total Current Assets | ₹3,000 Cr | ₹2,487 Cr | ₹2,345 Cr | ₹2,326 Cr | ₹2,347 Cr |
Net Current Assets (Including Current Investments) | ₹2,317 Cr | ₹1,776 Cr | ₹1,819 Cr | ₹1,640 Cr | ₹1,619 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹5,657 Cr | ₹5,109 Cr | ₹4,792 Cr | ₹4,588 Cr | ₹4,303 Cr |
Contingent Liabilities | ₹15 Cr | ₹8.00 Cr | ₹1.20 Cr | ₹1.10 Cr | ₹2.80 Cr |
Total Debt | ₹165 Cr | ₹404 Cr | ₹266 Cr | ₹316 Cr | ₹386 Cr |
Book Value | - | 233.44 | 224.88 | 206.04 | 189.49 |
Adjusted Book Value | 267.06 | 233.44 | 224.88 | 206.04 | 189.49 |
Compare Balance Sheet of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹17,882.2 Cr | 0.8% | -6.7% | 74% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 0.8% |
-6.7% |
74% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses